phenylalanine has been researched along with levetiracetam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G | 1 |
| Dericioglu, N; Saygi, S | 1 |
2 other study(ies) available for phenylalanine and levetiracetam
| Article | Year |
|---|---|
Antimyoclonic effect of levetiracetam in MERRF syndrome.
Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Humans; Levetiracetam; MERRF Syndrome; Middle Aged; Mitochondria; Muscle, Skeletal; Mutation; Myoclonus; Phenylalanine; Piracetam; Quality of Life; RNA, Transfer; Treatment Outcome; Ubiquinone; Valproic Acid | 2006 |
Generalized seizures aggravated by levetiracetam in an adult patient with phenylketonuria.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Female; Fructose; Humans; Levetiracetam; Phenylalanine; Phenylketonurias; Piracetam; Topiramate; Treatment Outcome; Young Adult | 2010 |